{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T07:01:13Z","timestamp":1767855673885,"version":"3.49.0"},"reference-count":77,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2015.00122","type":"journal-article","created":{"date-parts":[[2015,6,9]],"date-time":"2015-06-09T08:54:45Z","timestamp":1433840085000},"source":"Crossref","is-referenced-by-count":19,"title":["Gender differences in pharmacokinetics and pharmacodynamics of methadone substitution therapy"],"prefix":"10.3389","volume":"6","author":[{"given":"Manuela","family":"Graziani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Nistic\u00c3\u00b2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2015,6,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1472-8206.2004.00230.x","article-title":"Sex differences in ventricular repolarization: from cardiac electrophysiology to Torsades de Pointes.","volume":"18","author":"Abi-Gerges","year":"2004","journal-title":"Fundam. Clin. Pharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.drugalcdep.2014.10.014","article-title":"Ethnic and genetic factors in methadone pharmacokinetics: a population pharmacokinetic study.","volume":"145","author":"Bart","year":"2014","journal-title":"Drug. Alcohol Depend."},{"issue":"47","key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2007.07.003","article-title":"Sex differences in drug abuse.","volume":"29","author":"Becker","year":"2008","journal-title":"Front. Neuroendocrinol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1093\/ndt\/gfl227","article-title":"Differences in decline in GFR with age between males and females. Reference data on clearances of inulin and PAH in potential kidney donors.","volume":"21","author":"Berg","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"B5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.phrs.2009.02.006","article-title":"Influence of sex and CYP2D6 genotype on mirtazapine disposition, evaluated in Spanish healthy volunteers.","volume":"59","author":"Borobia","year":"2009","journal-title":"Pharmacol. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1067\/mcp.2001.116793","article-title":"Pharmacokinetics and pharmacodynamics of methadone enantiomers after a single oral dose of racemate.","volume":"70","author":"Boulton","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00007691-200102000-00001","article-title":"Methadone maintenance treatment: is it possible to adapt the daily doses to the metabolic activity of the patient?","volume":"23","author":"Charlier","year":"2001","journal-title":"Ther. Drug. Monit."},{"key":"B8","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.pbb.2008.05.023","article-title":"Sex and opioid maintenance dose influence response to naloxone in opioid-dependent humans: a retrospective analysis.","volume":"90","author":"Chopra","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B9","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/BF00194951","article-title":"Pharmacokinetics of methadone and its primary metabolite in 20 opiate addicts.","volume":"48","author":"de Vos","year":"1995","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"e86114","key":"B10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086114","article-title":"Impact of ABCB1 and CYP2B6 genetic polymorphisms on methadone metabolism, dose and treatment response in patients with opioid addiction: a systematic review and meta-analysis.","volume":"29","author":"Dennis","year":"2014","journal-title":"PLoS ONE"},{"key":"B11","doi-asserted-by":"publisher","first-page":"575","DOI":"10.2165\/00002018-200124080-00002","article-title":"Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome.","volume":"24","author":"Drici","year":"2001","journal-title":"Drug Saf."},{"key":"B12","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0009-9236(99)90090-5","article-title":"Steady-state pharmacokinetics and pharmacodynamics in methadone maintenance patients: comparison of those who do and do not experience withdrawal and concentration-effect relationships.","volume":"65","author":"Dyer","year":"1999","journal-title":"Clin. Pharmacol. Ther."},{"key":"B13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/00004714-200102000-00014","article-title":"The relationship between mood state and plasma methadone concentration in maintenance patients.","volume":"21","author":"Dyer","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.2165\/00003088-200241140-00003","article-title":"Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence.","volume":"41","author":"Eap","year":"2002","journal-title":"Clin. Pharmacokinet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s002280050128","article-title":"Replacement of (R)-methadone by a double dose of (R,S)-methadone in addicts: interindividual variability of the (R)\/(S) ratios and evidence of adaptive changes in methadone pharmacokinetics.","volume":"50","author":"Eap","year":"1996","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/02791072.2010.10399783","article-title":"Gender differences in psychiatric symptomatology in adolescents attending a community drug and alcohol treatment program.","volume":"42","author":"Edokpolo","year":"2010","journal-title":"J. Psychoactive Drugs"},{"key":"B17","author":"EMCDDA.","year":"2014","journal-title":"European Monitoring Centre for Drugs and Drug Addiction"},{"key":"B18","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.phrs.2004.05.002","article-title":"Methadone\u00e2\u20ac\u201cmetabolism, pharmacokinetics and interactions.","volume":"50","author":"Ferrari","year":"2004","journal-title":"Pharmacol. Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jpainsymman.2004.03.003","article-title":"Characterization of the early pharmacodynamic profile of oral methadone for cancer-related breakthrough pain: a pilot study.","volume":"28","author":"Fisher","year":"2004","journal-title":"J. Pain Symptom Manage."},{"key":"B20","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1046\/j.1365-2125.1999.00921.x","article-title":"Methadone N-demethylation in human liver microsomes: lack of stereoselectivity and involvement of CYP3A4.","volume":"47","author":"Foster","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1046\/j.1365-2125.2000.00272.x","article-title":"Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patients.","volume":"50","author":"Foster","year":"2000","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/j.1365-2125.2004.02079.x","article-title":"Population pharmacokinetics of (R)-, (S)- and rac-methadone in methadone maintenance patients.","volume":"57","author":"Foster","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.ejpain.2006.09.006","article-title":"Long term methadone for chronic pain: a pilot study of pharmacokinetic aspects.","volume":"11","author":"Fredheim","year":"2007","journal-title":"Eur. J. Pain."},{"key":"B24","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S1056-8719(00)00043-5","article-title":"Methadone: a review of its pharmacokinetic\/pharmacodynamic properties.","volume":"42","author":"Garrido","year":"1999","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"B25","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0740-5472(99)00008-2","article-title":"Three oral formulations of methadone. A clinical and pharmacodynamic comparison.","volume":"17","author":"Gourevitch","year":"1999","journal-title":"J. Subst. Abuse Treat."},{"key":"B26","first-page":"55","article-title":"Gender and use of substance abuse treatment services.","volume":"29","author":"Green","year":"2006","journal-title":"Alcohol Res. Health"},{"key":"B27","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0740-5472(02)00278-7","article-title":"Gender differences in predictors of initiation, retention, and completion in an HMO-based substance abuse treatment program.","volume":"23","author":"Green","year":"2002","journal-title":"J. Subst. Abuse Treat."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2006.05.012","article-title":"Substance abuse treatment entry, retention, and outcome in women: a review of the literature.","volume":"86","author":"Greenfield","year":"2007","journal-title":"Drug. Alcohol Depend."},{"key":"B29","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0889-8545(03)00072-X","article-title":"Epidemiology of substance use disorders in women.","volume":"30","author":"Greenfield","year":"2003","journal-title":"Obstet. Gynecol. Clin. North Am."},{"key":"B30","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.ahj.2007.01.040","article-title":"Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes.","volume":"153","author":"Gupta","year":"2007","journal-title":"Am. Heart J."},{"key":"B31","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1365-2125.2001.01328.x","article-title":"Influence of gender and oral contraceptives on CYP2D6 and CYP2C19 activity in healthy volunteers.","volume":"51","author":"H\u00c3\u00a4gg","year":"2001","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/j.1365-2125.2005.02464.x","article-title":"Within- and between- subject variability in methadone pharmacokinetics and pharmacodynamics in methadone maintenance subjects.","volume":"60","author":"Hanna","year":"2005","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.drugalcdep.2004.02.001","article-title":"Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment.","volume":"74","author":"Hernandez-Avila","year":"2004","journal-title":"Drug Alcohol Depend."},{"key":"B34","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s002130050963","article-title":"Rated well-being in relation to plasma concentrations of l- and d-methadone in satisfied and dissatisfied patients on methadone maintenance treatment.","volume":"143","author":"Hiltunen","year":"1999","journal-title":"Psychopharmacology (Berl)."},{"key":"B35","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/clpt.1987.47","article-title":"Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain.","volume":"41","author":"Inturrisi","year":"1987","journal-title":"Clin. Pharmacol. Ther."},{"key":"B36","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/clpt.1990.77","article-title":"Pharmacokinetic-pharmacodynamic relationships of methadone infusions in patients with cancer pain.","volume":"47","author":"Inturrisi","year":"1990","journal-title":"Clin. Pharmacol. Ther."},{"key":"B37","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/00008571-199810000-00005","article-title":"Quantification of intraindividual variability and the influence of menstrual cycle phase on CYP2D6 activity as measured by dextromethorphan phenotyping.","volume":"8","author":"Kashuba","year":"1998","journal-title":"Pharmacogenetics"},{"key":"B38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.drugalcdep.2012.12.025","article-title":"Sex differences in cocaine\/heroin users: drug-use triggers and craving in daily life.","volume":"132","author":"Kennedy","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"B39","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1097\/00008571-200007000-00006","article-title":"Effect of gender, sex hormones, time variables and physiological urinary pH on apparent CYP2D6 activity as assessed by metabolic ratios of marker substrates.","volume":"10","author":"Labb\u00c3\u00a9","year":"2000","journal-title":"Pharmacogenetics"},{"key":"B40","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.clpt.2005.11.013","article-title":"MDR1 genotype is associated with hepatic cytochrome P450 3A4 basal and induction phenotype.","volume":"79","author":"Lamba","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"key":"B41","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1124\/jpet.103.054866","article-title":"Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression.","volume":"307","author":"Lamba","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B42","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/BF03256276","article-title":"Interindividual variability of methadone response: impact of genetic polymorphism.","volume":"8","author":"Li","year":"2008","journal-title":"Mol. Diagn. Ther."},{"key":"B43","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00213-002-1183-2","article-title":"Biological basis of sex differences in drug abuse: preclinical and clinical studies.","volume":"164","author":"Lynch","year":"2002","journal-title":"Psychopharmacology (Berl)."},{"key":"B44","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000081416","article-title":"QTc interval prolongation in patients on long-term methadone maintenance therapy.","volume":"11","author":"Maremmani","year":"2005","journal-title":"Eur. Addict. Res."},{"issue":"534523","key":"B45","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/534523","article-title":"Novel psychoactive substances and behavioral addictions.","volume":"2014","author":"Martinotti","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"B46","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1365-2125.2004.02221.x","article-title":"Subjective and physiological responses among racemic-methadone maintenance patients in relation to relative (S)- vs. (R)-methadone exposure.","volume":"58","author":"Mitchell","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B47","author":"NIDA.","year":"2014","journal-title":"National Institute on Drug Abuse."},{"key":"B48","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.drugalcdep.2006.08.017","article-title":"Women-only and mixed-gender drug abuse treatment programs: service needs, utilization and outcomes.","volume":"87","author":"Niv","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"B49","author":"NSDUH.","year":"2010","journal-title":"Substance Abuse, and Mental Health Services Administration. Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings (Office of Applied Studies, NSDUH Series H-38A, HHS Publication No. SMA 10-4586 Findings"},{"key":"B50","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/pds.1112","article-title":"QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system.","volume":"14","author":"Pearson","year":"2005","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"B51","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1300\/J069v25n02_06","article-title":"Gender differences and pregnant women in a methadone maintenance treatment (MMT) clinic.","volume":"25","author":"Peles","year":"2006","journal-title":"J. Addict. Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.drugalcdep.2005.03.021","article-title":"Patient perspectives on methadone maintenance treatment in the Valencia Region: dose adjustment, participation in dosage regulation, and satisfaction with treatment.","volume":"79","author":"P\u00c3\u00a9rez de Los Cobos","year":"2005","journal-title":"Drug Alcohol Depend."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/ki.2009.11","article-title":"Demographic and clinical characteristics associated with glomerular filtration rates in living kidney donors.","volume":"75","author":"Poggio","year":"2009","journal-title":"Kidney Int."},{"key":"B54","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1093\/jat\/27.6.332","article-title":"Methadone and metabolite urine concentrations in patients maintained on methadone.","volume":"27","author":"Preston","year":"2003","journal-title":"J. Anal. Toxicol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1046\/j.1365-2125.1999.00974.x","article-title":"Population pharmacokinetics of methadone in opiate users: characterization of time-dependent changes.","volume":"48","author":"Rostami-Hodjegan","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.drugalcdep.2010.09.003","article-title":"Initiation to drug injection among street youth: a gender-based analysis.","volume":"114","author":"Roy","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"B57","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.schres.2013.04.017","article-title":"Differences in associations between cannabis and stimulant disorders in first admission psychosis.","volume":"147","author":"Sara","year":"2013","journal-title":"Schizophr. Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1177\/0269881105056660","article-title":"New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 (\u00e2\u20ac\u00b2Blue Mystic\u00e2\u20ac\u00b2).","volume":"19","author":"Schifano","year":"2005","journal-title":"J. Psychopharmacol."},{"key":"B59","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0022-3565(25)12089-2","article-title":"Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms.","volume":"275","author":"Schuetz","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B60","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0026-895X(24)26457-9","article-title":"Altered expression of hepatic cytochromes P-450 in mice deficient in one or more mdr1 genes.","volume":"57","author":"Schuetz","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.addbeh.2010.08.008","article-title":"Sex differences amongst dependent heroin users: histories, clinical characteristics and predictors of other substance dependence.","volume":"36","author":"Shand","year":"2011","journal-title":"Addict. Behav."},{"key":"B62","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1046\/j.1365-2125.2003.01851.x","article-title":"A discordance between cytochrome P450 2D6 genotype and phenotype in patients undergoing methadone maintenance treatment.","volume":"56","author":"Shiran","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1365-2125.2008.03312.x","article-title":"Contribution of the activities of CYP3A, CYP2D6 CYP1A2 and other potential covariates to the disposition of methadone in patients undergoing methadone maintenance treatment.","volume":"67","author":"Shiran","year":"2009","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1081\/JA-120027764","article-title":"Gender and other factors associated with the non-medical use of abusable prescription drugs.","volume":"39","author":"Simoni-Wastila","year":"2004","journal-title":"Subst. Use Misuse."},{"key":"B65","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0376-8716(97)00099-9","article-title":"Drug abuse treatment retention and process effects on follow-up outcomes.","volume":"47","author":"Simpson","year":"1997","journal-title":"Drug Alcohol Depend."},{"key":"B66","doi-asserted-by":"publisher","first-page":"5777","DOI":"10.1523\/JNEUROSCI.5223-05.2006","article-title":"Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women.","volume":"26","author":"Smith","year":"2006","journal-title":"J. Neurosci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"4498","DOI":"10.1210\/jc.83.12.4498","article-title":"Brain opioid receptor measurements by positron emission tomography in normal cycling women: relationship to luteinizing hormone pulsatility and gonadal steroid hormones.","volume":"83","author":"Smith","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B68","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s002280100359","article-title":"The prevalence of CYP2D6 and CYP2C19 genotypes in a population of healthy Dutch volunteers.","volume":"57","author":"Tamminga","year":"2001","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1360-0443.2007.02056.x","article-title":"Gender and non-medical use of prescription opioids: results from a national US survey.","volume":"103","author":"Tetrault","year":"2008","journal-title":"Addiction"},{"key":"B70","first-page":"39406","article-title":"Guideline for the study and evaluation of gender differences in the clinical evaluation of drugs; notice.","volume":"58","author":"U.S. Food and Drug Administration.","year":"1993","journal-title":"Fed. Regist."},{"key":"B71","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/S0013-7006(06)76190-5","article-title":"Methadone: from pharmacokinetic profile to clinical pharmacology.","volume":"32","author":"Vazquez","year":"2006","journal-title":"Encephale"},{"key":"B72","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1053\/jhep.2003.50393","article-title":"Sex is a major determinant of CYP3A4 expression in human liver.","volume":"38","author":"Wolbold","year":"2003","journal-title":"Hepatology"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1046\/j.1360-0443.2000.951217717.x","article-title":"Population-based pharmacokinetic approach for methadone monitoring of opiate addicts: potential clinical utility.","volume":"95","author":"Wolff","year":"2000","journal-title":"Addiction"},{"key":"B74","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1046\/j.1365-2125.1997.t01-1-00591.x","article-title":"The pharmacokinetics of methadone in healthy subjects and opiate users.","volume":"44","author":"Wolff","year":"1997","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1365-2125.1993.tb05666.x","article-title":"Inhibition of human cytochrome P450 2D6 (CYP2D6) by methadone.","volume":"35","author":"Wu","year":"1993","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1146\/annurev.pharmtox.41.1.815","article-title":"Molecular basis of ethnic differences in drug disposition and response.","volume":"41","author":"Xie","year":"2001","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1176\/ajp.156.6.842","article-title":"Gender and age influences on human brain mu-opioid receptor binding measured by PET.","volume":"156","author":"Zubieta","year":"1999","journal-title":"Am. J. Psychiatry"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T12:27:24Z","timestamp":1748435244000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fphar.2015.00122\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,9]]},"references-count":77,"URL":"https:\/\/doi.org\/10.3389\/fphar.2015.00122","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,9]]}}}